Statement Of Unitholders' Equity

KYORIN Pharmaceutical Co., Ltd. - Filing #7603167

Concept As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
Statement of unitholders' equity
Statement of unitholders' equity
Net assets
39,185,000,000 JPY
-16,038,000,000 JPY
27,206,000,000 JPY
6,268,000,000 JPY
4,752,000,000 JPY
3,000,000 JPY
64,952,000,000 JPY
132,710,000,000 JPY
27,203,000,000 JPY
53,084,000,000 JPY
-17,671,000,000 JPY
13,899,000,000 JPY
700,000,000 JPY
120,491,000,000 JPY
4,016,000,000 JPY
110,000,000 JPY
-2,362,000,000 JPY
124,507,000,000 JPY
700,000,000 JPY
64,952,000,000 JPY
700,000,000 JPY
700,000,000 JPY
27,063,000,000 JPY
13,899,000,000 JPY
120,339,000,000 JPY
6,639,000,000 JPY
4,752,000,000 JPY
-2,275,000,000 JPY
53,084,000,000 JPY
-17,671,000,000 JPY
-16,038,000,000 JPY
124,661,000,000 JPY
39,185,000,000 JPY
64,812,000,000 JPY
132,557,000,000 JPY
64,812,000,000 JPY
4,322,000,000 JPY
-40,000,000 JPY
27,067,000,000 JPY
3,000,000 JPY
122,710,000,000 JPY
4,176,000,000 JPY
3,000,000 JPY
36,000,000 JPY
700,000,000 JPY
118,534,000,000 JPY
6,922,000,000 JPY
4,752,000,000 JPY
-17,706,000,000 JPY
-2,782,000,000 JPY
130,788,000,000 JPY
26,911,000,000 JPY
-16,053,000,000 JPY
700,000,000 JPY
26,908,000,000 JPY
13,899,000,000 JPY
39,185,000,000 JPY
53,084,000,000 JPY
64,642,000,000 JPY
64,642,000,000 JPY
Changes during period
Net changes in items other than shareholders' equity
151,000,000 JPY
-306,000,000 JPY
-371,000,000 JPY
-306,000,000 JPY
-86,000,000 JPY
506,000,000 JPY
146,000,000 JPY
-77,000,000 JPY
146,000,000 JPY
-282,000,000 JPY
Total changes during period
JPY
151,000,000 JPY
JPY
139,000,000 JPY
JPY
0 JPY
-306,000,000 JPY
139,000,000 JPY
-371,000,000 JPY
152,000,000 JPY
JPY
0 JPY
JPY
-154,000,000 JPY
139,000,000 JPY
139,000,000 JPY
152,000,000 JPY
-86,000,000 JPY
JPY
JPY
170,000,000 JPY
1,804,000,000 JPY
JPY
506,000,000 JPY
JPY
1,951,000,000 JPY
-77,000,000 JPY
146,000,000 JPY
-282,000,000 JPY
1,769,000,000 JPY
35,000,000 JPY
JPY
JPY
155,000,000 JPY
14,000,000 JPY
JPY
155,000,000 JPY
JPY
170,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.